Achieve Life Sciences shareholders approve doubling authorized common shares to 300M

ACHIEVE LIFE SCIENCES, INC.

Shareholders approved Certificate of Amendment increasing authorized common shares from 150M to 300M.
All nine director nominees elected, including Jeffrey Farrow, Andrew Goldberg, and others.
Ratification of PricewaterhouseCoopers LLP as independent auditor for FY 2026 approved.
Non-binding advisory vote on named executive officer compensation passed with 46.4M for, 0.6M against.
Certificate of Amendment filed with Delaware Secretary of State on July 6, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.